Figure 2
Figure 2. Examples for modulation of pulmonary melanoma metastasis through targeted interference with platelet receptors. In all experiments (performed by L.E. in the laboratory of M.P.S.), C57/BL6 mice were intravenously injected with 2.5 × 105 B16F10 melanoma cells, and pulmonary metastasis was evaluated after 10 to 14 days. (A) Antibody-mediated depletion of platelets prevents metastasis formation. (B) Inhibition of platelet GPIbα by function-blocking, monovalent Fab fragments results in a marked increase of pulmonary melanoma metastases. (C) Inhibition of GPIIb/IIIa by specific Fab fragments decreases the number of metastatic melanoma nodules in the lung. (D) Antibody-mediated blockade of GPVI does not significantly influence pulmonary melanoma metastasis. (E) P-selectin deficiency causes marked reduction of pulmonary melanoma metastasis.

Examples for modulation of pulmonary melanoma metastasis through targeted interference with platelet receptors. In all experiments (performed by L.E. in the laboratory of M.P.S.), C57/BL6 mice were intravenously injected with 2.5 × 105 B16F10 melanoma cells, and pulmonary metastasis was evaluated after 10 to 14 days. (A) Antibody-mediated depletion of platelets prevents metastasis formation. (B) Inhibition of platelet GPIbα by function-blocking, monovalent Fab fragments results in a marked increase of pulmonary melanoma metastases. (C) Inhibition of GPIIb/IIIa by specific Fab fragments decreases the number of metastatic melanoma nodules in the lung. (D) Antibody-mediated blockade of GPVI does not significantly influence pulmonary melanoma metastasis. (E) P-selectin deficiency causes marked reduction of pulmonary melanoma metastasis.

Close Modal

or Create an Account

Close Modal
Close Modal